Rheumnow
A Phase 3 Trial of a JAKi in Patients With Giant Cell Arteritis Sponsored by AbbVie Medical Affairs + Health Impact
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:14:49
- Mais informações
Informações:
Sinopse
Listen as coinvestigator and rheumatologist Dr. Andrea Rubbert-Roth reviews this Phase 3 trial of a JAKi in patients with giant cell arteritis. Dr. Rubbert-Roth discusses the latest results, including efficacy and safety outcomes.
